STRATA Skin Sciences, Inc. (SSKN) Balance Sheet
SSKN balance sheet, 2025
December 31, 2025 · U.S. dollars$30.5M assets = $27.6M liabilities + $2.9M equity
Both columns are drawn to the same scale: what SSKN owns equals what it owes plus shareholders’ equity. Hover a block for its value.
SSKN financial health
Descriptive bands, not a rating. Fiscal 2025.
SSKN balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $43.2M2016 | $30.5M2025 | −3.8%/yr | |
| Total liabilities | $28.5M2016 | $27.6M2025 | −0.3%/yr | |
| Shareholders’ equity | $14.7M2016 | $2.9M2025 | −16.5%/yr | |
| Cash & short-term investments | $3.9M2016 | $7.9M2025 | +8.1%/yr | |
| Total debt | $23.8M2016 | $16.3M2025 | −4.2%/yr | |
| Net cash (debt) | −$19.9M2016 | −$8.4M2025 | +$11.5M | |
| Working capital | $4.6M2016 | −$11.1M2025 | −$15.8M | |
| Book value per share | $6.362016 | $3.372017 | −47.0%/yr | |
| Current ratio | 1.752016 | 0.582025 | −1.17 | |
| Debt / equity | 1.622016 | 5.592025 | +3.98 | |
| Shares outstanding | 2.3M2016 | 6.6M2017 | +185.0%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
SSKN assets
SSKN liabilities and equity
SSKN debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
SSKN balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $7.9M | $7.3M | $6.8M | $5.4M | $12.6M | $10.6M | $8.1M | $16.5M | $4.1M | $3.9M |
| Cash & equivalents | $7.9M | $7.3M | $6.8M | $5.4M | $12.6M | $10.6M | $8.1M | $16.5M | $4.1M | $3.9M |
| Short-term investments | — | — | — | — | — | — | — | — | $0 | $0 |
| Receivables | $4.1M | $5.3M | $4.4M | $4.5M | $3.4M | $2.9M | $4.4M | $3.4M | $3.1M | $3.4M |
| Inventory | $2.8M | $2.2M | $2.7M | $5.5M | $3.5M | $3.4M | $3.0M | $2.8M | $3.0M | $2.8M |
| Other current assets | $753,000 | $1.8M | $1.6M | $2.1M | $462,000 | $7.8M | $8.0M | $536,000 | $533,000 | $617,000 |
| Total current assets | $15.6M | $16.6M | $15.5M | $17.5M | $20.0M | $24.8M | $23.6M | $23.2M | $10.8M | $10.8M |
| Property, plant & equipment (net) | $9.9M | $11.3M | $12.4M | $8.5M | $7.5M | $6.5M | $6.7M | $0 | $7.7M | $10.2M |
| Goodwill & intangible assets | $4.8M | $8.0M | $13.8M | $26.2M | $18.9M | $15.1M | $16.8M | $18.6M | $20.1M | $22.2M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $231,000 | $231,000 | $231,000 | $98,000 | $216,000 | $282,000 | $347,000 | $5.7M | $48,000 | $46,000 |
| Total assets | $30.5M | $36.2M | $42.0M | $52.3M | $46.6M | $46.8M | $47.3M | $47.5M | $38.6M | $43.2M |
| Liabilities | ||||||||||
| Accounts payable | $2.8M | $2.4M | $3.3M | $3.4M | $2.8M | $2.8M | $1.9M | $6.3M | $2.3M | $1.9M |
| Short-term debt | $15.6M | $328,000 | $352,000 | $355,000 | $318,000 | $9.1M | $7.6M | $252,000 | $2.7M | $2.1M |
| Deferred revenue | $2.2M | $2.2M | $2.1M | $2.8M | $3.3M | $2.3M | $2.8M | — | $291,000 | $235,000 |
| Total current liabilities | $26.7M | $14.6M | $12.2M | $13.4M | $12.8M | $18.8M | $17.4M | $8.6M | $7.7M | $6.1M |
| Long-term debt | $0 | $15.2M | $15.0M | $7.5M | $7.3M | $1.1M | $0 | $7.1M | $7.9M | $21.8M |
| Lease obligations | $919,000 | $1.2M | $589,000 | $965,000 | $710,000 | $1.1M | $1.4M | — | — | — |
| Other long-term liabilities | $872,000 | $1.4M | $2.1M | $9.5M | $1.1M | $998,000 | $1.3M | $499,000 | $861,000 | $561,000 |
| Total liabilities | $27.6M | $31.2M | $29.3M | $30.4M | $21.2M | $20.9M | $18.7M | $16.3M | $16.4M | $28.5M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $6,000 | $4,000 | $4,000 | $35,000 | $34,000 | $34,000 | $33,000 | $30,000 | $4,000 | $11,000 |
| Retained earnings (deficit) | −$254.4M | −$248.1M | −$238.1M | −$227.2M | −$221.7M | −$219.0M | −$214.6M | −$210.8M | −$229.4M | −$210.6M |
| Treasury stock | — | — | — | — | — | — | — | — | $0 | $0 |
| Accumulated other comprehensive income | — | — | $0 | — | — | $0 | −$13.5M | −$13.5M | −$10.7M | $2,000 |
| Minority interest | — | — | — | — | — | — | — | — | $0 | $0 |
| Total shareholders' equity | $2.9M | $5.0M | $12.7M | $21.8M | $25.4M | $25.9M | $28.7M | $31.2M | $22.2M | $14.7M |
| Key figures | ||||||||||
| Total debt | $16.3M | $16.4M | $15.6M | $8.4M | $8.0M | $10.9M | $8.7M | $7.4M | $10.6M | $23.8M |
| Net cash (debt) | −$8.4M | −$9.2M | −$8.8M | −$3.0M | $4.6M | −$278,000 | −$537,000 | $9.1M | −$6.5M | −$19.9M |
| Working capital | −$11.1M | $2.0M | $3.4M | $4.1M | $7.2M | $6.0M | $6.1M | $14.6M | $3.1M | $4.6M |
| Tangible book value | −$1.9M | −$3.0M | −$1.1M | −$4.4M | $6.5M | $10.7M | $11.9M | $12.7M | $2.1M | −$7.5M |
| Book value per share | — | — | — | — | — | — | — | — | $3.37 | $6.36 |
| Shares outstanding | — | — | — | — | — | — | — | — | 6.6M | 2.3M |
| Current ratio | 0.58 | 1.13 | 1.28 | 1.30 | 1.56 | 1.32 | 1.35 | 2.69 | 1.40 | 1.75 |
| Quick ratio | 0.45 | 0.86 | 0.92 | 0.74 | 1.25 | 0.72 | 0.72 | 2.31 | 0.94 | 1.19 |
| Debt / equity | 5.59 | 3.31 | 1.23 | 0.39 | 0.32 | 0.42 | 0.30 | 0.24 | 0.48 | 1.62 |
| Equity / assets | 9.5% | 13.8% | 30.2% | 41.8% | 54.5% | 55.4% | 60.5% | 65.8% | 57.6% | 34.1% |
| Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 | Mar '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $7.9M | $7.1M | $6.0M | $6.5M | $7.3M | $7.1M | $5.5M | $5.2M | $6.8M | $7.1M | $9.0M | $2.8M |
| Cash & equivalents | $7.9M | $7.1M | $6.0M | $6.5M | $7.3M | $7.1M | $5.5M | $5.2M | $6.8M | $7.1M | $9.0M | $2.8M |
| Receivables | $4.1M | $3.5M | $4.0M | $5.0M | $5.3M | $4.4M | $4.0M | $3.6M | $4.4M | $4.8M | $4.4M | $3.9M |
| Inventory | $2.8M | $3.1M | $3.2M | $2.7M | $2.2M | $2.7M | $2.7M | $2.7M | $2.7M | $6.1M | $5.9M | $5.7M |
| Other current assets | $753,000 | $634,000 | $550,000 | $1.7M | $1.8M | $1.6M | $1.7M | $1.7M | $1.6M | $1.7M | $1.9M | $2.1M |
| Total current assets | $15.6M | $14.3M | $13.8M | $15.9M | $16.6M | $15.9M | $13.8M | $13.2M | $15.5M | $19.7M | $21.2M | $14.5M |
| Property, plant & equipment (net) | $9.9M | $10.6M | $9.7M | $10.6M | $11.3M | $11.7M | $12.6M | $13.2M | $12.4M | $9.0M | $9.1M | $9.1M |
| Goodwill & intangible assets | $4.8M | $5.7M | $7.0M | $7.5M | $8.0M | $12.4M | $12.9M | $13.3M | $13.8M | $18.4M | $24.8M | $25.5M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $231,000 | $231,000 | $231,000 | $231,000 | $231,000 | $231,000 | $325,000 | $231,000 | $231,000 | $71,000 | $71,000 | $82,000 |
| Total assets | $30.5M | $30.7M | $30.7M | $34.3M | $36.2M | $40.2M | $39.6M | $40.0M | $42.0M | $47.2M | $55.2M | $49.1M |
| Liabilities | ||||||||||||
| Accounts payable | $2.8M | $3.0M | $2.9M | $2.8M | $2.4M | $1.7M | $2.9M | $3.6M | $3.3M | $3.2M | $3.9M | $3.1M |
| Short-term debt | $15.6M | $2.4M | $303,000 | $331,000 | $328,000 | $322,000 | $313,000 | $300,000 | $352,000 | $404,000 | $392,000 | $381,000 |
| Deferred revenue | $2.2M | $2.6M | $2.4M | $2.2M | $2.2M | $2.4M | $2.3M | $2.4M | $2.1M | $2.4M | $2.4M | $2.5M |
| Total current liabilities | $26.7M | $15.0M | $14.0M | $15.1M | $14.6M | $14.0M | $12.1M | $12.6M | $12.2M | $12.0M | $14.1M | $13.1M |
| Long-term debt | $0 | $13.4M | $15.3M | $15.2M | $15.2M | $15.2M | $15.1M | $15.1M | $15.0M | $15.0M | $15.0M | $7.5M |
| Lease obligations | $919,000 | $1.0M | $1.1M | $1.2M | $1.2M | $1.3M | $1.4M | $1.5M | $589,000 | $686,000 | $779,000 | $870,000 |
| Other long-term liabilities | $872,000 | $935,000 | $1.1M | $1.2M | $1.4M | $1.7M | $2.8M | $3.0M | $2.1M | $4.0M | $9.2M | $9.2M |
| Total liabilities | $27.6M | $29.4M | $30.4M | $31.6M | $31.2M | $30.9M | $30.1M | $30.6M | $29.3M | $31.0M | $38.3M | $29.8M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $6,000 | $5,000 | $4,000 | $4,000 | $4,000 | $4,000 | $4,000 | $35,000 | $4,000 | $35,000 | $35,000 | $35,000 |
| Retained earnings (deficit) | −$254.4M | −$254.5M | −$253.1M | −$250.6M | −$248.1M | −$243.6M | −$241.5M | −$241.4M | −$238.1M | −$234.3M | −$233.2M | −$230.1M |
| Accumulated other comprehensive income | — | — | — | — | — | — | — | $0 | $0 | — | — | — |
| Total shareholders' equity | $2.9M | $1.3M | $308,000 | $2.7M | $5.0M | $9.3M | $9.5M | $9.4M | $12.7M | $16.2M | $16.9M | $19.3M |
| Key figures | ||||||||||||
| Total debt | $16.3M | $16.3M | $16.4M | $16.4M | $16.4M | $16.5M | $16.5M | $16.5M | $15.6M | $15.7M | $15.8M | $8.4M |
| Net cash (debt) | −$8.4M | −$9.2M | −$10.4M | −$9.9M | −$9.2M | −$9.4M | −$11.0M | −$11.3M | −$8.8M | −$8.6M | −$6.7M | −$5.6M |
| Working capital | −$11.1M | −$761,000 | −$230,000 | $737,000 | $2.0M | $1.8M | $1.7M | $651,000 | $3.4M | $7.7M | $7.1M | $1.5M |
| Tangible book value | −$1.9M | −$4.3M | −$6.7M | −$4.8M | −$3.0M | −$3.0M | −$3.4M | −$3.9M | −$1.1M | −$2.2M | −$7.9M | −$6.2M |
| Book value per share | $0.49 | — | — | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 5.9M | — | — | — | — | — | — | — | — | — | — | — |
| Current ratio | 0.58 | 0.95 | 0.98 | 1.05 | 1.13 | 1.13 | 1.14 | 1.05 | 1.28 | 1.64 | 1.50 | 1.11 |
| Quick ratio | 0.45 | 0.70 | 0.71 | 0.76 | 0.86 | 0.82 | 0.78 | 0.70 | 0.92 | 0.99 | 0.95 | 0.52 |
| Debt / equity | 5.59 | 12.41 | 53.09 | 6.14 | 3.31 | 1.76 | 1.74 | 1.75 | 1.23 | 0.97 | 0.93 | 0.43 |
| Equity / assets | 9.5% | 4.3% | 1.0% | 7.8% | 13.8% | 23.2% | 24.0% | 23.6% | 30.2% | 34.3% | 30.6% | 39.3% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 26, 2026); data from EODHD.
SSKN financial position
At the end of fiscal 2025 (December 31, 2025), STRATA Skin Sciences had total assets of $30.5 million (down 15.6% from a year earlier), total liabilities of $27.6 million and shareholders' equity of $2.9 million. It held $7.9 million in cash and short-term investments against $16.3 million of debt, net debt of $8.4 million. Its current ratio was 0.58.
Related: SSKN income statement, SSKN cash flow statement, SSKN key metrics. See the SSKN stock overview for the latest quote and news.
SSKN balance sheet FAQ
What are STRATA Skin Sciences's total assets?
STRATA Skin Sciences reported total assets of $30.5 million at the end of fiscal 2025 (December 31, 2025), compared with $36.2 million a year earlier.
How much debt does STRATA Skin Sciences have?
STRATA Skin Sciences had $16.3 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 5.59.
How much cash does STRATA Skin Sciences have?
STRATA Skin Sciences held $7.9 million in cash and short-term investments at the end of fiscal 2025; with $16.3 million of debt that is net debt of $8.4 million.
What is STRATA Skin Sciences's book value?
STRATA Skin Sciences's shareholders' equity (book value) was $2.9 million at the end of fiscal 2025.
What is STRATA Skin Sciences's current ratio?
STRATA Skin Sciences had current assets of $15.6 million and current liabilities of $26.7 million, a current ratio of 0.58 (current liabilities exceed current assets).
How much goodwill does STRATA Skin Sciences have?
STRATA Skin Sciences carried $4.8 million of goodwill and intangible assets, 15.7% of total assets, at the end of fiscal 2025.